💰 Business
Live
Sanofi Raises FY26 Outlook Amid Strong Dupixent Sales
Sanofi’s Q2 net profit fell due to one-time charges, but core business earnings rose 29% driven by Dupixent sales. This operational strength validates its strategic shift, prompting the company to rai
Nasdaq News — 29 July 2026
Text:
23
0
0
Sanofi reported a dramatic drop in its second-quarter net profit to €343 million, down sharply from €3.9 billion a year ago, even as its core business
Read Full Story at Nasdaq News → Sources
💰 Business
What does a Burnham-led government mean for your money?
💰 Business
Vietnam fines crypto users $1,900 for trading on Binance
💰 Business
Ryanair profits tumble as jet fuel costs soar
💰 Business
CXMT becomes most valuable listed company in mainland China at 3.3 trillion yuan
💰 Business
PGA Tour, DPWT announce alliance with Asian Tour, dealing blow to LIV Golf
💰 Business
UK complacent about war threat, warns defence boss
